Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
25.03. | Abingdon Health progresses at-home STD test programme | 1 | Sharecast | ||
25.03. | Abingdon Health PLC - Design freeze completion & strategic partnership | - | RNS | ||
20.03. | Abingdon Health to launch two Boots-branded self-tests | 1 | Sharecast | ||
20.03. | Abingdon Health strikes deal amidst upswing in self testing market | 1 | Alliance News | ||
20.03. | AIM WINNERS & LOSERS: Abingdon Health rises on Boots agreement | 1 | Alliance News | ||
20.03. | Three Quick Facts: Computacenter, Prudential, Abingdon Health | 10 | The Armchair Trader | ||
20.03. | Abingdon Health PLC - Launch of OEM self-tests in Boots | - | RNS | ||
15.03. | Abingdon Health PLC - CEO Interview | - | RNS | ||
14.03. | Abingdon Health PLC - Interim Results | - | RNS | ||
11.03. | Abingdon Health PLC - Notice of Results | - | RNS | ||
11.01. | Abingdon Health shares down despite decent interim results | 1 | Alliance News | ||
11.01. | Abingdon Health PLC - Update to Shareholder Concert Parties | - | RNS | ||
11.01. | Abingdon Health PLC - Trading Update | - | RNS | ||
15.12.23 | Abingdon Health upbeat on strong recent progress | 1 | Sharecast | ||
15.12.23 | Abingdon Health PLC - Result of AGM | - | RNS | ||
15.12.23 | Abingdon Health PLC - AGM Statement | - | RNS | ||
22.11.23 | Abingdon Health PLC - Notice of Annual General Meeting | - | RNS | ||
25.10.23 | Abingdon Health PLC - Director/PDMR Shareholding | - | RNS | ||
24.10.23 | Abingdon Health appoints Feather as new interim finance director | 1 | Alliance News | ||
24.10.23 | Abingdon Health PLC - Award of Options under LTIP | - | RNS |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 51,18 | 0,00 % | HV-Kalender: Aktionärs-Versammlungen u.a. bei Beiersdorf, Covestro, LVMH, Newron, Siemens Healthineers, Stellantis | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 36,430 | 0,00 % | FMC-Aktie mit Kursverlusten (55,0585 €) | Im Minus liegt zur Stunde der Anteilsschein von FMC . Das Papier kostete zuletzt 58,59 US-Dollar. Eine Verbilligung in Höhe von 2,95 US-Dollar müssen derzeit die Aktionäre von FMC hinnehmen. Gegenwärtig... ► Artikel lesen | |
FRESENIUS | 26,650 | 0,00 % | Fresenius - geht da was? | Der DAX-Konzern Fresenius will sich neu organisieren und hat deshalb - nach fast 30 Jahren Zusammenarbeit - die Fresenius Medical Care (FMC) dekonsolidiert?. Zusätzlich hat der Gesundheitskonzern für... ► Artikel lesen | |
MOBILE-HEALTH NETWORK SOLUTIONS | 20,220 | 0,00 % | Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange | SINGAPORE, April 15, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR), a pioneering Asia-Pacific (APAC) telehealth provider, celebrates its successful initial public offering... ► Artikel lesen | |
CARL ZEISS MEDITEC | 97,65 | 0,00 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die schweizerische Großbank UBS hat die Einstufung für Carl Zeiss Meditec auf "Buy" mit einem Kursziel von 130 Euro belassen. Analyst Graham Doyle taucht in dieser am Freitag... ► Artikel lesen | |
GERRESHEIMER | 100,00 | 0,00 % | JPMORGAN stuft GERRESHEIMER AG auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Gerresheimer nach Zahlen für erste Geschäftsquartal von 123,20 auf 125,70 Euro angehoben und die Einstufung auf "Overweight" belassen.... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 51,08 | 0,00 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
PROGYNY | 31,880 | -2,66 % | Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care | ||
ADAPTHEALTH | 9,360 | -0,74 % | Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank | ||
EUROPEAN WAX CENTER | 11,300 | +4,05 % | European Wax Center, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results | Fiscal Year 2023 versus 2022 Net new centers increased 10.6% to 1,044 total centers in 45 statesSystem-wide sales of $955.0 million increased 6.3%Total revenue of $221.0 million increased 6.6%Same-store... ► Artikel lesen | |
NANO-X IMAGING | 9,070 | 0,00 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
RXSIGHT | 51,75 | -2,04 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 5,710 | +0,35 % | LifeStance Health Group, Inc.: LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024 | ||
AGILON HEALTH | 5,385 | 0,00 % | agilon health Reports Fourth Quarter 2023 Results | AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the fourth quarter... ► Artikel lesen | |
LIFEMD | 10,190 | +3,24 % | LifeMD, Inc.: LifeMD Reports Fourth Quarter 2023 Results | Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period.Adjusted EPS of $0.15 per share compared with $0.02 in the year-ago... ► Artikel lesen |